| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/01/2009 | EP2075256A2 Multispecific binding molecules |
| 07/01/2009 | EP2075255A1 Human FGF-23 gene and gene expression products |
| 07/01/2009 | EP2075254A1 Therapeutic use of a growth factor, NsG33 |
| 07/01/2009 | EP2075253A1 Compositions and methds for the diagnosis and treatment of disorders involving angiogensis |
| 07/01/2009 | EP2074229A1 Reliable detection of vancomycin-intermediate staphylococcus aureus |
| 07/01/2009 | EP2074222A2 Methods and compositions for the detection of protein folding disorders |
| 07/01/2009 | EP2074217A1 Expression of tgf-beta in plastids |
| 07/01/2009 | EP2074209A2 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells |
| 07/01/2009 | EP2074142A1 Compounds for stimulating p-glycoprotein function and uses thereof |
| 07/01/2009 | EP2074141A1 Protease resistant insulin analogues |
| 07/01/2009 | EP2074140A2 Fibrillation-resistant insulin and insulin analogues |
| 07/01/2009 | EP2074139A2 Il-1 family variants |
| 07/01/2009 | EP2074138A1 Neuroprotective peptide inhibitors of ap-1 signaling and uses therefor |
| 07/01/2009 | EP2074137A1 Compounds as aptamer-dimers and their uses in diagnosis and therapy |
| 07/01/2009 | EP2073897A2 Compositions and methods for modulating tlr14 activity |
| 07/01/2009 | EP2073837A2 Recombinant modified vaccinia ankara encoding a her-2 antigen for use in treating cancer |
| 07/01/2009 | EP2073834A2 Methods for administering long-lasting hypoglycemic agents |
| 07/01/2009 | EP2073829A2 Stabilized therapeutic small helical antiviral peptides |
| 07/01/2009 | EP1937818A4 Gene cry7bal encoding an insecticidal crystal protein of bacillus thuringiensis |
| 07/01/2009 | EP1907847A4 Identification of human t2r receptors that are activated by bitter molecules in coffee (chlorogenic lactones) and related assays for identifying human bitter taste modulators |
| 07/01/2009 | EP1831252B1 Glp-1 analog fusion protein formulations |
| 07/01/2009 | EP1831247B1 Hetero-oligomeric hiv envelope proteins |
| 07/01/2009 | EP1814908A4 Activated labeling reagents and methods for preparing and using the same |
| 07/01/2009 | EP1680506B1 Meg1 endosperm-specific promoters and genes |
| 07/01/2009 | EP1677665A4 Determination of ions using ion-sensitive enzymes |
| 07/01/2009 | EP1673633B1 Method for detecting feline immunodeficiency virus |
| 07/01/2009 | EP1673106B1 Optimized expression of hpv 45 l1 in yeast |
| 07/01/2009 | EP1666048A4 Method for producing insulin from a natural source and insulin |
| 07/01/2009 | EP1648930B1 Method of peptide synthesis |
| 07/01/2009 | EP1583564B1 Improved linkers for radiopharmaceutical compounds |
| 07/01/2009 | EP1576159B1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/01/2009 | EP1551222B1 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny |
| 07/01/2009 | EP1545577A4 Igf-binding protein-derived peptide or small molecule |
| 07/01/2009 | EP1534318A4 Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis |
| 07/01/2009 | EP1377165B1 Tsg101-gag interaction and use thereof |
| 07/01/2009 | EP1351967B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/01/2009 | EP1315417B1 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor |
| 07/01/2009 | EP1312675B1 Protein induced by homogeneous blood transfusion and dna encoding the same |
| 07/01/2009 | EP1261704B1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/01/2009 | EP1250154B1 G-csf conjugates |
| 07/01/2009 | EP1214678A4 System and method for processing tokenless biometric electronic transmissions using an electronic rule module clearinghouse |
| 07/01/2009 | EP1203025B1 Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and beta1 integrins |
| 07/01/2009 | EP1124846B1 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 07/01/2009 | EP1104310B1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 07/01/2009 | EP1080216B1 Retroviral delivery system |
| 07/01/2009 | EP0915973B1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 07/01/2009 | EP0871748B1 Delivery of biologically active polypeptides |
| 07/01/2009 | EP0784688B1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 07/01/2009 | CN101472945A Saquinavir derivatives useful in immunoassay |
| 07/01/2009 | CN101472944A Peptide fragments for inducing synthesis of extracellular matrix proteins |
| 07/01/2009 | CN101472943A SPARC-derived cancer rejection antigen peptide and pharmaceutical comprising the same |
| 07/01/2009 | CN101472942A Novel polypeptides and use thereof |
| 07/01/2009 | CN101472941A High titer recombinant influenza viruses for vaccines |
| 07/01/2009 | CN101469329A Compositions and methods for increasing bone mineralization |
| 07/01/2009 | CN101469020A Rare minnow beta type estrogen receptor and use thereof |
| 07/01/2009 | CN101469019A Cellular membrane protein DERLIN-1, preparation and use thereof |
| 07/01/2009 | CN101469018A Interleukin 2-interleukin 6-interleukin 23 trimer protein and use thereof |
| 07/01/2009 | CN101469017A Synthetic peptide vaccines for foot-and-mouth disease |
| 07/01/2009 | CN100507563C N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination |
| 07/01/2009 | CN100506999C Optimized expression of HPV 31 L1 in yeast |
| 07/01/2009 | CN100506989C Mosaic infections bursal disease virus vaccines |
| 07/01/2009 | CN100506986C Nucleic acid encoding GAI gene of arabidopsis thaliana |
| 07/01/2009 | CN100506980C Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequence and their therapeutic use |
| 07/01/2009 | CN100506845C IFNAR2 mutants, their production and use |
| 07/01/2009 | CN100506844C Novel peptides |
| 07/01/2009 | CN100506843C Novel gene necessary for production of conidium from Magnaporthe grisea and its uses |
| 07/01/2009 | CN100506842C Gene MgPPF5 for controlling invasion nail forming efficiency in fungus and its uses |
| 06/30/2009 | US7554020 Inbred maize line PHDRW |
| 06/30/2009 | US7554009 Generation of plants with altered oil content |
| 06/30/2009 | US7554006 Using plants as bioreactor for production of insulin; treating diabetes |
| 06/30/2009 | US7554005 Expression vector comprising regulatory sequences for use in propagation of disease and insect resistant plants; biological pest control and tissue egineering |
| 06/30/2009 | US7554004 Allelic series of genomic modifications in cells |
| 06/30/2009 | US7554003 transgenic Drosophila whose genome is homozygous for the loechrig (loe) allele and for the Drosophila beta-amyloid precursor-like deletion allele; enhanced vacuolization, sterility in female Drosophila, neurodegeneration, accumulation of fatty acids in the brain; reduction of cholesterol ester; Alzheimer |
| 06/30/2009 | US7553956 Nucleotide sequence probes for detecting beer-spoilage lactic acid bacteria; food processing and alcoholic beverages |
| 06/30/2009 | US7553946 stationary phase-specific promoter activity in gram positive bacteria; isolated DNA; expression vector; host cell; kits; culturing |
| 06/30/2009 | US7553941 Long-acting polypeptides and methods of producing same |
| 06/30/2009 | US7553940 comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to an EPO (erythropoietin) peptide ; improving a biological half life of an hGH polypeptide |
| 06/30/2009 | US7553939 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma |
| 06/30/2009 | US7553937 Specific antibodies for diagnosing heart failure |
| 06/30/2009 | US7553935 Modified vitamin K-dependent polypeptides |
| 06/30/2009 | US7553934 Enhanced membrane binding affinity; blood coagulation |
| 06/30/2009 | US7553933 Human p51 genes and gene products thereof |
| 06/30/2009 | US7553932 chronic arenavirus or a herpes virus; interleukin-10 receptor (IL-10R) |
| 06/30/2009 | US7553931 Convertase for use in identifying modulator for treatment and prevention of arthritis, kidney, inflammatory, heart and nervous system disorders |
| 06/30/2009 | US7553930 B-cell activation factor for use in diagnosis, prevention and treatment of glomerulonephritis and autoimmune diseases |
| 06/30/2009 | US7553929 Administering nuclear factor kappa beta (nf-kb)peptide nuclear localization sequence to inhibit import of stress-responsive transcription factor; septic shock, skin disorders, autoimmune diseases |
| 06/30/2009 | US7553927 Which direct localization of polynucleotides; nucleic acid of given sequence that hybridizes with probe; modifies photosynthesis and synthesis of fatty acids, amino acids, oils, carotenoids and starch |
| 06/30/2009 | US7553926 Therapeutic amino acid sequences for prevention and treatment of lymphadenopathy associated viral infection: viricides |
| 06/30/2009 | US7553832 Tuberculosis; inhibition of protein autosplicing of intein-containing proteins; using various drugs, for example 2-methyl-4-((4-methyl-1,3,4-thiadiazol-2-yl)thio)quinoline or 1,2,3-trimethylsulfonyl-5-trifluoromethylbenzene |
| 06/30/2009 | US7553814 Cancer drug target; useful in diagnostic, prophylactic, prognostic, of certain cancers |
| 06/30/2009 | US7553811 administering a CD200 fusion protein; tranplant rejection, fetal loss, autoimmune disease, and allergies; immunosuppresant |
| 06/30/2009 | US7553810 Methods and compositions for sealing localized regions of damaged lung tissue to reduce overall lung volume, glue featuring an adhering moiety coupled to one or more other moieties including a cross-linkable moiety and/or one other adhering moiety; use in treating pulmonary conditions, emphysema, copd |
| 06/30/2009 | US7553674 Expression vector comprising nucleotide sequences coding transport protein for use in diagnosis, prevention and treatment of vision, kidney and muscular disorders |
| 06/30/2009 | US7553668 transgenic plant; host cell; isolated nucleic acid molecule; nucleic acid sequences encoding the coat protein ; DNA expression vector; disease resistance |
| 06/30/2009 | US7553665 alternative media free from animal sources; Chinese hamster ovary (CHO) cells; Asparagine, Sodium Chloride, Selenite, Wheat hydrolysate and Insulin |
| 06/30/2009 | US7553659 CHD5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 06/30/2009 | US7553655 Transgenic cells for use as bioreactors in expression of amidated peptides |
| 06/30/2009 | US7553650 Polynucleotide encoding a mutant transglutaminase |
| 06/30/2009 | US7553642 Capable of sodium-independently transporting branched amino acids |
| 06/30/2009 | US7553639 Alpha-synuclein kinase |